FDA Recalls Finder

FDA Statement on Makena
8 November 2011, 1:49 pm

FDA approved Makena (hydroxyprogesterone caproate) in February 2011 for the reduction of the risk of certain preterm births in women who have had at least one prior preterm birth.

Source: Food and Drug Administration--Press Releases